New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 31, 2014
16:08 EDTXNCRXencor reports Q2 EPS (16c), consensus (19c)
Reports Q2 revenue $824K, consensus $1.44M. Based on current operating plans, Xencor expects to have sufficient cash to fund research and development programs and operations through 2016, and maintains the 2014 year-end cash and cash equivalents estimate of approximately $54.0M.
News For XNCR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 12, 2014
11:17 EDTXNCRLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
November 11, 2014
15:43 EDTXNCRLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
November 10, 2014
16:14 EDTXNCRXencor maintains 2014 year end cash, equivalents view approximately $54M
Subscribe for More Information
16:12 EDTXNCRXencor reports Q3 EPS (20c), consensus (19c)
Reports Q3 revenue $800,000, consensus $1.17M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use